Lympid
PrivateLast Round
Accelerator
May 21, 2024
Total Funding Raised
$100,000
Company Overview
Lympid is a financial technology company that provides a platform to tokenize and fractionalize real-world assets such as real estate, private equity, and luxury goods, enabling businesses to launch fundraising campaigns and investors to purchase fractional shares.
Sector
FinTech
Verticals
Tokenization, Investment Platforms, Blockchain Infrastructure, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS, Payment Processing Fee, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lympid Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lympid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 21, 2024 | ||||
| Strategic | Jun 22, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Accelerator | Nov 1, 2022 | ||||
| Pre Seed | Oct 1, 2022 |
Lympid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GAINS Associates | Pre Seed |
| Building Global Innovators | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 70% MoM.
- Jan 31, 2026
Monthly visitors grew 71% MoM, from 2.9K to 5K.
Lympid Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lympid's valuation, stock price, and market status.